Commercialisation & licensing

Our IP&T experts have guided some of Australia's most successful technology companies from start-up to global success. We have extensive experience in licensing a range of technologies (patented and know-how) in Australia and around the world, including in China, Germany, India, Japan, Korea, South Africa, the UK and the USA.

Our team is able to assist you with:

  • developing collaborative research and development agreements
  • setting up ownership structures
  • due diligence
  • structuring and negotiating patent licensing
  • commercialisation of technology and licensing
  • IP strategy
  • the acquisition and sale of intellectual property assets
  • protection of technology and intellectual asset management
  • IT contracts including outsourcing and service agreements
  • franchising and distribution agreements
  • commercialisation of plant varieties
  • patent infringement and revocation proceedings
  • training and educational seminars to ensure that a company is IP Ready and able to capitalise upon its valuable IP.


Licensing agreement for Progen Pharmaceuticals Ltd: We assisted Progen on their licence agreement with Medigen Biotechnology Corporation for the development and commercialisation of its drug candidate PG545 for the prevention and treatment for a certain type of liver cancer and non-oncology indications globally. Our assistance began at an early stage, providing Progen with strategic advice at the term-sheet stage regarding the structure of the deal, drafting the licensing agreement and assisting with the negotiations.

Licensing of vaccine technology from research institution for a listed client: We assisted our listed client in licensing a novel vaccine technology for dengue fever, vaccine technologies aimed at preventing hepatitis and influenza, and also in negotiating research agreements for the development of vaccine technology for eye conditions. Our work for this client has involved multiple transactions with public sector research organisations, liaison with academic researchers, and the successful management of stakeholder expectations.


T +61 2 8233 9556
Doyles Guide leading list rankings

Rob McInnes - Recommended Lawyer in Intellectual Property (Australia, 2016) and Preeminent Lawyer in Commercialisation IP (NSW, 2017)

DibbsBarker - Recommended Firm in Intellectual Property (Queensland, 2017) and Third Tier Law Firm in Intellectual Property (NSW, 2017)

Doyles Guide is an independent guide with rankings compiled through feedback from those in the legal profession.

Recent News and Publications
22 Feb 2018
From 22 February 2018, businesses subject to the new mandatory data breach notification regime will face penalties of up to $1.8 million if they fail to report data breaches in circumstances where serious harm could occur to an individual whose data has been compromised.
06 Dec 2017
The Privacy Amendment (Notifiable Data Breaches) Act 2017 (Cth) applies to government agencies, private sector organisations with annual turnovers over $3m, and all organisations handling health information or involved in credit reporting.
12 Oct 2017
Various news outlets have now reported far and wide that, after becoming aware of a pop-up bar said to have incorporated various themes from the Stranger Things series, Netflix’s IP counsel sent the bar’s owners a cease and desist letter.